Cargando…
Assessment of Risk Factors for Drug Resistance of Dual Anti Platelet Therapy After PCI
Since aspirin and clopidogrel are the widely and conventionally used drugs to treat acute myocardial infarction after percutaneous coronary intervention (PCI), it is important to explore potential risk factors of their resistance. The platelet aggregation rate with arachidonic acid (AA, PAg-AA%) and...
Autores principales: | Zhang, Lijie, Lv, Ying, Dong, Jianyu, Wang, Nana, Zhan, Zhan, Zhao, Yuan, Jiang, Shanshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921763/ https://www.ncbi.nlm.nih.gov/pubmed/35275501 http://dx.doi.org/10.1177/10760296221083674 |
Ejemplares similares
-
Safety and Efficacy Evaluation of Antithrombotic Therapy with Rivaroxaban and Clopidogrel After PCI in Chinese Patients
por: Bai, Long, et al.
Publicado: (2022) -
The age, NT-proBNP, and Ejection Fraction Score as a Novel Predictor
of Clinical Outcomes in CAD Patients After PCI
por: Fan, Lei, et al.
Publicado: (2022) -
Safety of Bivalirudin Combined with Ticagrelor in the Emergency PCI in Patients with Acute ST-Segment Elevation Myocardial Infarction
por: Wang, Zheng-Dong, et al.
Publicado: (2022) -
Risk factors and prediction nomogram model for 1-year readmission for major adverse cardiovascular events in patients with STEMI after PCI
por: Yao, Wensen, et al.
Publicado: (2022) -
Lymphocytes, Mean Platelet Volume, and Albumin in Critically Ill COVID-19 Patients
with Venous Thromboembolism
por: Duan, Rundan, et al.
Publicado: (2023)